FDA Drug Safety Oversight Board holds first meeting
Executive Summary
FDA will post a summary of the Drug Safety Oversight Board's inaugural meeting on its website on or around June 24, the agency says. The board convened June 17 to review organization and logistics, but did not discuss specific products, the agency said. The board will hold monthly meetings for the first six months of the board's inception (1"The Pink Sheet" May 23, 2005, p. 6)...
You may also be interested in...
FDA Names Drug Safety Board Members; First Meeting In Early Summer
Department of Veterans Affairs pharmacy benefit management advisor Chester Good brings experience with drug-related adverse event reporting to FDA's Drug Safety Oversight Board
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.